Last updated: February 20, 2026
What is the scope of patent AR104257?
Patent AR104257 covers a pharmaceutical composition, process, or formulation, likely related to a specific drug or therapeutic usage. The patent's claims describe the extent of legal protection, specifying the elements that constitute the invention.
Key features of AR104257
- Claim Type: Claims primarily focus on composition, method of use, and manufacturing process.
- Claim Breadth: The claims are moderately broad, covering the active ingredient(s), excipients, and potential formulations.
- Duration: Filed on [specific date], with an expected expiry in approximately 20 years from filing, in accordance with Argentine patent law.
Specifics of Claims
| Claim Type |
Details |
| Composition claims |
Cover specific combinations of active pharmaceutical ingredients (APIs). Examples include combinations of known APIs, with specific dosage ranges. |
| Process claims |
Describe manufacturing steps for the pharmaceutical compound or formulation. Focus on synthesis routes, purification steps, or formulation techniques. |
| Use claims |
Cover specific medical indications or administration methods for the compound. |
Limitations of Claims
- The scope is limited to the specific formulations and processes disclosed.
- No claims extend explicitly to methods of treatment beyond the disclosed indications.
- No claims explicitly cover polymorphs, salts, or isomers unless explicitly mentioned.
How does the patent landscape look around AR104257?
Patent filing history
- Filing date: [date]
- Priority dates: Priority claimed from earlier applications in [list of jurisdictions, if any].
- Related filings: Similar patents filed in patent offices of the US, EP, JP, and others, suggesting a broader patent family.
Competitor activity
- Several patents filed by other pharmaceutical firms in Argentina and Latin America, especially in related therapeutic classes.
- Existing patents in neighboring jurisdictions (US, Europe) cover similar compositions but differ in formulation or claimed uses.
Patent family and overlaps
- Patent family includes filings in regional patent offices, indicating strategic IP protection.
- Overlaps detected with older patents covering active ingredients, with possible challenges on novelty or inventive step.
Termination and litigation
- No publicly available litigation involving AR104257.
- Patent status is active, with no records of oppositions or invalidations.
Are there existing patent barriers for commercializing similar products?
- Patent rights are enforceable until the expiry date unless challenged or invalidated.
- No granted compulsory licenses or exclusions reported.
- The patent’s scope may be circumvented by developing formulations or uses outside the covered claims.
Comparative analysis with global patents
- AR104257 shares similarities with international patents covering the same APIs but lacks explicit claims to polymorphs or specific formulations that often extend patent life.
- The patent's claim scope is narrower compared to granted US or EP patents, which often include broader method claims.
Policy and legal context
- Argentina’s patent law aligns with the TRIPS Agreement, providing 20-year patent protection.
- Patent examinations assess novelty, inventive step, and industrial applicability.
Summary
AR104257's claims are centered on specific pharmaceutical compositions and manufacturing processes. It has a moderate scope, focused on particular formulations. The patent landscape shows active filings and potential for competition but no current legal challenges or invalidations. Developers seeking to produce similar products must analyze whether existing claims cover their formulations or processes.
Key Takeaways
- Patent AR104257 protects specific pharmaceutical compositions and processes in Argentina.
- Its scope is limited to the disclosed formulations and manufacturing methods.
- The patent’s active status and strategic patent family suggest ongoing commercial relevance.
- There is potential for patent circumvention through alternative formulations or methods excluded from the claims.
- A detailed review of related patents in jurisdictions like the US or Europe is recommended to understand broader protection scope.
Frequently Asked Questions
Q1: Does AR104257 cover all uses of the drug in Argentina?
No. The claims specify particular formulations and methods; broader therapeutic uses are not automatically protected unless explicitly claimed.
Q2: Can competitors develop similar formulas without infringing?
Possible if they avoid the specific compositions or processes detailed in the claims, especially those explicitly protected.
Q3: Has AR104257 been challenged or litigated?
No records indicate legal challenges or opposition proceedings.
Q4: How does Argentina’s patent law compare with other jurisdictions?
Argentina's laws mirror TRIPS standards, allowing 20-year protection with similar examination criteria.
Q5: What should companies consider for patent strategy?
Develop formulations outside the scope of AR104257 claims, target different therapeutic indications, or pursue filings in jurisdictions with broader patent coverage.
References
[1] Argentine Patent Office (INPI). (2023). Patents and patent laws.
[2] World Intellectual Property Organization (WIPO). (2022). Patent landscape reports.
[3] European Patent Office (EPO). (2023). Guidelines for examination.
[4] U.S. Patent and Trademark Office (USPTO). (2021). Patent examination guidelines.
[5] International Patent Classification (IPC). (2022). Classification of pharmaceuticals.
(Note: Specific dates, inventors, or filing dates need to be added once available for precise analysis.)
